Pancreatic Cancer Research

ResearcherWestern University of Health SciencesNo recent work listed

Sunil V. Prabhu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-2463-6233; OpenAlex author ID A5103695850; NIH RePORTER profile ID 8391770. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 9)
Trials
0
Grants
2
Labs led
1
Collaborators
6
Papers, trials and grants by year

2012: 1 paper, 1 grant · 2013: 2 papers · 2014: 1 grant · 2015: 2 papers · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: 2 papers · 2020: 1 paper

Papers 10

  1. Efficacy and Pharmacokinetic Considerations of Loratadine Nanoformulations and its Combinations for Pancreatic Cancer Chemoprevention. Last author DOI 10.1007/s11095-019-2737-x↗
  2. Loratadine self-microemulsifying drug delivery systems (SMEDDS) in combination with sulforaphane for the synergistic chemoprevention of pancreatic cancer. Last author DOI 10.1007/s13346-019-00619-0↗
  3. Pancreatic Cancer: Recent Advances in Nanoformulation-Based Therapies. Last author DOI 10.1615/critrevtherdrugcarriersyst.2018025459↗
  4. Novel nano-drug combination therapeutic regimen demonstrates significant efficacy in the transgenic mouse model of pancreatic ductal adenocarcinoma. Last author PMID 30416852↗
  5. Triptolide and celastrol loaded silk fibroin nanoparticles show synergistic effect against human pancreatic cancer cells. Co-author DOI 10.1039/c7nr03016a↗
  6. Ferulic acid combined with aspirin demonstrates chemopreventive potential towards pancreatic cancer when delivered using chitosan-coated solid-lipid nanopartic… Last author DOI 10.1186/s13578-015-0041-y↗
  7. Evaluation of ibuprofen loaded solid lipid nanoparticles and its combination regimens for pancreatic cancer chemoprevention. Last author DOI 10.3892/ijo.2015.2879↗
  8. A novel combinatorial nanotechnology-based oral chemopreventive regimen demonstrates significant suppression of pancreatic cancer neoplastic lesions. Last author DOI 10.1158/1940-6207.capr-13-0172↗
  9. The molecular mechanism of action of aspirin, curcumin and sulforaphane combinations in the chemoprevention of pancreatic cancer. Last author DOI 10.3892/or.2013.2276↗
  10. Chemoprevention of pancreatic cancer using solid-lipid nanoparticulate delivery of a novel aspirin, curcumin and sulforaphane drug combination regimen. Last author DOI 10.3892/ijo.2012.1636↗

Grants 2

  1. Combinatorial nanotechnology-based regimens for pancreatic cancer chemoprevention R15CA182834↗
  2. Chemoprevention of pancreatic cancer using a combinatorial nano-drug system R03CA153812↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jeffrey Wang · 10 shared papers, 2012–2020 · strength 0.85
  2. Arvind D. Thakkar · 8 shared papers, 2012–2019 · strength 0.57
  3. Preshita Prafulla Desai · 4 shared papers, 2018–2020 · strength 0.49
  4. B. Karthik Grandhi · 3 shared papers, 2012–2013 · strength 0.14
  5. Dhruvitkumar S. Sutaria · 2 shared papers, 2012–2013 · strength 0.09
  6. Baoyue Ding · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.